1) valdecoxib
戊地昔布
1.
Relationship between antitumor effect of valdecoxib and COX-2 expression;
戊地昔布的抑瘤作用与COX-2的表达及活性的关系
2.
COX-2 involved in the antitumor effect of valdecoxib on Lewis tumor;
COX-2参与戊地昔布抑制Lewis肿瘤的生长
3.
Apoptosis was involved in the antitumor effect of valdecoxib on Lewis cancer;
戊地昔布抑制Lewis肿瘤生长的作用
2) oxybutynin
奥昔布宁
1.
High performance liquid chromatographic separation of oxybutynin enantiomers using chiral mobile phase additive;
高效液相色谱手性流动相添加法拆分奥昔布宁对映体
2.
Studies on oral osmotic pump tablet of oxybutynin coated with Eudragit RS 30D;
水分散体包衣制备奥昔布宁渗透泵片
3.
Study on the preparation of Oxybutynin gel;
盐酸奥昔布宁凝胶剂的制备
3) lumiracoxib
罗美昔布
4) Refecoxib
罗非昔布
1.
Evidence-Based Safety Reassessment of Post Marketed Drug — Importance of Recall of Refecoxib;
应重视上市后药物安全性的循证医学再评价——罗非昔布召回的意义
2.
A clinical study of Refecoxib and antibiotics for treatment of chronic prostatitis;
罗非昔布联合抗生素治疗慢性前列腺炎
5) celecoxib
塞来昔布
1.
Study on the mechanism of celecoxib on synergetic anti-tumor role in gastric cancer in vitro;
塞来昔布增强胃癌化疗药物疗效的机制研究
2.
Effects of Celecoxib on Expression of VEGF-C and bcl-2 mRNA in Prostate Cancer PC-3 Cell Lines;
塞来昔布对前列腺癌细胞株PC-3中VEGF-C及bcl-2 mRNA表达的影响
6) rofecoxib
罗非昔布
1.
Analysis of withdrawal of rofecoxib-cyclooxygenase-2 specific inhibitor;
高选择性COX-2抑制剂罗非昔布撤市分析
2.
Effect of selective cyclooxygenase-2 inhibitor rofecoxib on the growth of human carcinoma of gallbladder;
选择性环氧合酶-2抑制剂罗非昔布对胆囊癌生长的影响
3.
Effect of rofecoxib on expressions of VEGF and inducible NOS in human gastric carcinoma tissues established in nude mice by orthotopic transplantation;
罗非昔布对裸鼠人胃癌原位种植瘤组织中血管内皮生长因子和诱导型一氧化氮合酶表达的影响
补充资料：地昔帕明
分子式：
CAS号：
性质： 又名去甲丙咪嗪。液体。沸点172～174℃(2.67Pa)。其盐酸盐为白色结晶粉末。无臭，味苦，对光、热和空气不稳定。熔点214～218℃。溶于水。由二苯并氮杂卓为原料制得。为抗抑郁药，有阻滞草胺类神经介质如去甲肾上腺素或5-羟色胺回收的作用。用于治疗各种抑郁症。
CAS号：
性质： 又名去甲丙咪嗪。液体。沸点172～174℃(2.67Pa)。其盐酸盐为白色结晶粉末。无臭，味苦，对光、热和空气不稳定。熔点214～218℃。溶于水。由二苯并氮杂卓为原料制得。为抗抑郁药，有阻滞草胺类神经介质如去甲肾上腺素或5-羟色胺回收的作用。用于治疗各种抑郁症。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条